title: Exacerbation of macular oedema associated with hyperbaric oxygen therapy.
authors: Associated Retinal Consultants, Royal Oak, Michigan, USA.|Department of Ophthalmology, Oakland University William Beaumont School of Medicine, Royal Oak, Michigan, USA.
authors: Yoshihiro
authors: Y
authors: Yonekawa
authors: Department of Neurology and Ophthalmology, Michigan State University, East Lansing, Michigan, USA.|Department of Ophthalmology, Oakwood Southshore Medical Center, Trenton, Michigan, USA.
authors: Stephen M
authors: SM
authors: Hypes
authors: Texas Retina Associates, Dallas, Texas, USA.
authors: Ashkan M
authors: AM
authors: Abbey
authors: Associated Retinal Consultants, Royal Oak, Michigan, USA.|Department of Ophthalmology, Oakland University William Beaumont School of Medicine, Royal Oak, Michigan, USA.
authors: George A
authors: GA
authors: Williams
authors: Associated Retinal Consultants, Royal Oak, Michigan, USA.|Department of Ophthalmology, Oakland University William Beaumont School of Medicine, Royal Oak, Michigan, USA.
authors: Jeremy D
authors: JD
authors: Wolfe
mesh_terms: D000368:Aged; D017542:Aneurysm, Ruptured / Q000150:complications / Q000628:therapy; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D005260:Female; D005451:Fluorescein Angiography; D006801:Humans; D006931:Hyperbaric Oxygenation / Q000009:adverse effects*; D008269:Macular Edema / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000209:etiology*; D000069579:Ranibizumab / Q000627:therapeutic use; D012161:Retinal Artery / Q000473:pathology; D012164:Retinal Diseases / Q000150:complications / Q000628:therapy; D041623:Tomography, Optical Coherence; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors
chemical_list: D020533:Angiogenesis Inhibitors; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D000069579:Ranibizumab